FindTrial
Sign In

To screen the key lncRNA in the occurrence and development of luminal B breast cancer using RNA-seq

To screen the key lncRNA in the occurrence and development of luminal B breast cancer using RNA-seq

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-BON-17011203
Enrollment
Unknown
Registered
2017-04-20
Start date
2017-06-01
Completion date
Unknown
Last updated
2017-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Luminal B type breast cancer tissue:extracte Total RNA from tissue samples
luminal B breast cancer Paracancer tissue:extracte Total RNA from tissue samples

Sponsors

People's Hospital of Deyang City
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) patients with definitive diagnosis of luminal B breast cancer; (2) patients with early luminal B breast cancer (TNM stage I / II without metastasis); (3) patients without chemotherapy before chemotherapy, radiotherapy Treatment; (4) patients older than 18 years of age.

Exclusion criteria

Exclusion criteria: (1) patients with a history of cancer or in the diagnosis found concurrent with other tumors; (2) patients with luminal B breast cancer diagnosed with TNMIII and IV; (3) breast cancer patients diagnosed with other subtypes.

Design outcomes

Primary

MeasureTime frame
LncRNA expression;mRNA expression;—

Countries

China

Contacts

Public ContactChengliang Yuan

People's Hospital of Deyang City

dyyuancl@163.com+86 0838-2418493

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026